These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15731095)

  • 1. Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
    Infect Immun; 2005 Mar; 73(3):1890-4. PubMed ID: 15731095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
    Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
    J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn SJ
    Int Immunol; 2005 May; 17(5):607-13. PubMed ID: 15802307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
    Infect Immun; 2005 Jan; 73(1):181-92. PubMed ID: 15618153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
    J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.
    Miyahira Y; Katae M; Takeda K; Yagita H; Okumura K; Kobayashi S; Takeuchi T; Kamiyama T; Fukuchi Y; Aoki T
    Infect Immun; 2003 Mar; 71(3):1234-41. PubMed ID: 12595437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
    Ilyinskii PO; Wang R; Balk SP; Exley MA
    J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.
    Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR
    Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation.
    Shi MQ; Wang CR; Wei GJ; Pan WL; Appleyard G; Tabel H
    Parasite Immunol; 2006 Dec; 28(12):643-7. PubMed ID: 17096643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A specific ligand of V alpha 14 NKT cells and its presentation].
    Harada M; Taniguchi M
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
    [No Abstract]   [Full Text] [Related]  

  • 18. During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.
    Duthie MS; Kahn SJ
    Immunology; 2006 Nov; 119(3):355-61. PubMed ID: 16879622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.
    Lieke T; Graefe SE; Klauenberg U; Fleischer B; Jacobs T
    Infect Immun; 2004 Dec; 72(12):6817-25. PubMed ID: 15557602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.